Hepatitis: Difference between revisions
Usama Talib (talk | contribs) |
|||
Line 82: | Line 82: | ||
* Fecal-oral transmission | * Fecal-oral transmission | ||
* Usually acute and self limit | * Usually acute and self limit | ||
* [[Fever]] | * [[Fever]] usually present | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis B]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis B]] | ||
Line 94: | Line 94: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | --- | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | --- | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Percutaneous transmission | * Percutaneous transmission most common | ||
* May cause acute hepatic failure or | * May cause acute hepatic failure or may become chronic | ||
* [[Fever]] | * [[Fever]] usually present | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis C]] | ||
Line 108: | Line 108: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Percutaneous transmission is | * Percutaneous transmission is most common | ||
* Higher rate of chronic progression | * Higher rate of chronic progression | ||
* Associated with extra hepatic manifestation such as | * Associated with extra hepatic manifestation such as [[cryoglobulinemia]] and [[membranoproliferative glomerulonephritis]] | ||
* [[Fever]] | * [[Fever]] usually present | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis E]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Hepatitis E]] | ||
Line 124: | Line 124: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Fecal-oral transmission | * Fecal-oral transmission | ||
* May cause fulminant disease in | * May cause fulminant disease in pregnancy | ||
* [[Fever]] | * [[Fever]] usually present | ||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cytomegalovirus infection natural history, complications and prognosis|CMV hepatitis]] | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[Cytomegalovirus infection natural history, complications and prognosis|CMV hepatitis]] | ||
Line 136: | Line 136: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |CMV-specific immunoglobulin (Ig)M antibody | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |CMV-specific immunoglobulin (Ig)M antibody | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Usually manifests as mononucleosis syndrome | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Usually manifests as mononucleosis syndrome | |||
* [[fever]] usually present | |||
|- | |- | ||
| style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[EBV]] hepatitis | | style="padding: 5px 5px; background: #DCDCDC;" align="center" |[[EBV]] hepatitis | ||
Line 147: | Line 149: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antibody|Heterophile antibody test]], monospot test | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antibody|Heterophile antibody test]], monospot test | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>--</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Systemic manifestations as mononucleosis syndrome | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Systemic manifestations as mononucleosis syndrome | |||
* Fever usually present | |||
|- | |- | ||
| colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Autoimmune hepatitis | | colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Autoimmune hepatitis | ||
Line 158: | Line 162: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antinuclear antibodies|ANA]], [[Anti-SM antibody|ASMA]], anti SLA/LP, [[ANCA]], ALKM-1 antibodies | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |[[Antinuclear antibodies|ANA]], [[Anti-SM antibody|ASMA]], anti SLA/LP, [[ANCA]], ALKM-1 antibodies | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |Liver biopsy may be required for diagnosis | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* Liver biopsy may be required for diagnosis | |||
|- | |- | ||
| colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Alcoholic hepatitis | | colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Alcoholic hepatitis | ||
Line 169: | Line 174: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | --- | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | --- | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |History of alcohol intake | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* History of alcohol intake | |||
|- | |- | ||
| colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Drug induced hepatitis | | colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |Drug induced hepatitis | ||
Line 180: | Line 186: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |<nowiki>---</nowiki> | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" |May cause either cholestatic or hepatocellular injury | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
* May cause either cholestatic or hepatocellular injury | |||
|} | |} | ||
Revision as of 21:33, 27 July 2017
For patient information click here.
Hepatitis Main Page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Seyedmahdi Pahlavani, M.D. [2], Usama Talib, BSc, MD [3]
Overview
Hepatitis refers to any injury to the liver that may result in inflammation. The etiologic agent could be infectious (almost always viral) or non-infectious. Depending on the disease course they could be classified as acute or chronic. Acute viral hepatitis are a spectrum of systemic inflammatory conditions that predominantly involve the liver. Hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV), the HBV-associated delta agent or hepatitis D virus (HDV), and hepatitis E virus (HEV) are the most common viruses that may cause acute viral hepatitis. Alcoholic hepatitis and and non alcoholic steatohepatitis (NASH) are the most common non-infectious hepatitis. Many drugs and toxins may also result in hepatic injury. The common manifestation among hepatitis patients are, fever, jaundice, fatigue, abdominal pain, and hepatomegaly. Diagnosis is based on clinical manifestation and laboratory findings. In rare conditions liver biopsy is required for either diagnosis or treatment plan. In some cases disease may progress to chronic course and result in multiple complications such as, hepatocellular carcinoma (HCC), cirrhosis, or hepatorenal syndrome. In such conditions liver transplantation is the best treatment.
Classification
Hepatitis may be classified based on etiology in to two major category.
- Infectious causes
- Non-infectious causes
Infectious Causes
Infectious hepatitis classified according to viral agent in to 7 major category.
|
Non-Infectious Hepatitis
Non-infectious Hepatitis | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Alcoholic hepatitis | Non-alcoholic steatohepatitis (NASH) | Alpha 1 antitrypsin deficiency | Autoimmune hepatitis | Obstructive hepatitis | Drug related hepatitis | Toxin related hepatitis | Ischemic hepatitis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
•Gallstones •Tumors | •Isoniazid •NSAIDs •Beta-lactam antibiotics •Sulfa-containing drugs •HAART | Chemicals | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Another classification scheme for hepatitis is based on duration of disease which may classified as Acute vs Chronic.
Differential diagnosis
Hepatitis must be differentiated from other conditions that may cause fever, fatigue, nausea and vomiting, and elevated liver enzymes.
Disease | Clinical manifestations | Laboratory findings | Additional findings | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Signs | Transaminitis (elevated AST and ALT) | Viral markers | Autoimmune markers | ||||||
Nausea & vomiting | Abdominal pain | Arthralgia | Jaundice | Hepatomegaly | ||||||
Acute viral hepatitis | Hepatitis A | +++ | ++ | + | +++ | + | +++ | HAV Ab | --- |
|
Hepatitis B | +++ | ++ | ++ | +++ | + | +++ | HBs Ag, HBc Ab, HBe Ag | --- |
| |
Hepatitis C | +++ | ++ | ++ | +++ | + | +++ | HCV Ab | --- |
| |
Hepatitis E | ++ | ++ | +/- | ++ | + | +++ | HEV Ab | --- |
| |
CMV hepatitis | +/- | ++ | - | + | + | ++ | CMV-specific immunoglobulin (Ig)M antibody | -- |
| |
EBV hepatitis | +/- | ++ | - | +/- | + | ++ | Heterophile antibody test, monospot test | -- |
| |
Autoimmune hepatitis | - | + | +/- | ++ | + | +++ | --- | ANA, ASMA, anti SLA/LP, ANCA, ALKM-1 antibodies |
| |
Alcoholic hepatitis | +/- | + | - | + | - | AST>ALT | --- | --- |
| |
Drug induced hepatitis | +/- | + | - | + | + | ++ | --- | --- |
|